Tingyan Shi
No ORCID on file
· 1 paper in corpus
2022
In the post-PARP inhibitor era, potential changes in tumor biology after maintenance therapy have not been well investigated in recurrent ovarian cancer. We reported a case with alterations in the clinical and histological features of multi…